MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer

BACKGROUND: In the absence of targetable mutations or immune checkpoints, cisplatin-doublet chemotherapy remains the standard of care in non-small cell lung cancer (NSCLC). Drug resistance has however become a significant clinical challenge. Exploring a role for small non-coding microRNAs (miRNA) as...

Descripción completa

Detalles Bibliográficos
Autores principales: MacDonagh, Lauren, Gallagher, Michael F., Ffrench, Brendan, Gasch, Claudia, Gray, Steven G., Reidy, Marie, Nicholson, Siobhan, Leonard, Niamh, Ryan, Ronan, Young, Vincent, O’Leary, John J., Cuffe, Sinead, Finn, Stephen P., O’Byrne, Kenneth J., Barr, Martin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107736/
https://www.ncbi.nlm.nih.gov/pubmed/34012792
http://dx.doi.org/10.21037/tlcr-20-959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107736/
https://www.ncbi.nlm.nih.gov/pubmed/34012792
http://dx.doi.org/10.21037/tlcr-20-959

Ejemplares similares